IPSC
Price
$1.04
Change
+$0.06 (+6.12%)
Updated
Dec 24 closing price
Capitalization
90.9M
77 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$1.11
Change
+$0.02 (+1.83%)
Updated
Dec 24 closing price
Capitalization
69.11M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSC vs PYXS

Header iconIPSC vs PYXS Comparison
Open Charts IPSC vs PYXSBanner chart's image
Century Therapeutics
Price$1.04
Change+$0.06 (+6.12%)
Volume$1.86M
Capitalization90.9M
Pyxis Oncology
Price$1.11
Change+$0.02 (+1.83%)
Volume$1.42M
Capitalization69.11M
IPSC vs PYXS Comparison Chart in %
IPSC
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IPSC vs. PYXS commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a StrongBuy and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (IPSC: $1.04 vs. PYXS: $1.11)
Brand notoriety: IPSC and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 135% vs. PYXS: 127%
Market capitalization -- IPSC: $90.9M vs. PYXS: $69.11M
IPSC [@Biotechnology] is valued at $90.9M. PYXS’s [@Biotechnology] market capitalization is $69.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, IPSC is a better buy in the long-term than PYXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 7 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • IPSC’s TA Score: 7 bullish, 4 bearish.
  • PYXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than PYXS.

Price Growth

IPSC (@Biotechnology) experienced а +55.83% price change this week, while PYXS (@Biotechnology) price change was -67.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

IPSC is expected to report earnings on Mar 12, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSC($90.9M) has a higher market cap than PYXS($69.1M). IPSC YTD gains are higher at: 2.970 vs. PYXS (-28.846). IPSC has higher annual earnings (EBITDA): -909K vs. PYXS (-83.07M). IPSC has more cash in the bank: 133M vs. PYXS (76.3M). PYXS has less debt than IPSC: PYXS (19.1M) vs IPSC (45M). IPSC has higher revenues than PYXS: IPSC (113M) vs PYXS (2.82M).
IPSCPYXSIPSC / PYXS
Capitalization90.9M69.1M132%
EBITDA-909K-83.07M1%
Gain YTD2.970-28.846-10%
P/E RatioN/AN/A-
Revenue113M2.82M4,007%
Total Cash133M76.3M174%
Total Debt45M19.1M236%
TECHNICAL ANALYSIS
Technical Analysis
IPSCPYXS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDRIF0.29N/A
+1.05%
New Stratus Energy Inc.
PRBZF74.600.55
+0.74%
Premium Brands Holding Corp.
CLVLY8.75N/A
N/A
Clinuvel Pharmaceuticals Ltd.
MPFRY10.05N/A
N/A
Mapfre SA
QQQFF0.03N/A
N/A
Quizam Media Corporation

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CDXS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+6.19%
CDXS - IPSC
48%
Loosely correlated
+1.82%
IMNM - IPSC
43%
Loosely correlated
+2.76%
CRSP - IPSC
42%
Loosely correlated
+0.44%
MGX - IPSC
42%
Loosely correlated
+1.16%
SYRE - IPSC
41%
Loosely correlated
-0.54%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with HOWL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+1.83%
HOWL - PYXS
44%
Loosely correlated
+5.04%
IPSC - PYXS
39%
Loosely correlated
+6.19%
GANX - PYXS
38%
Loosely correlated
+4.55%
DAWN - PYXS
37%
Loosely correlated
-0.31%
BEAM - PYXS
37%
Loosely correlated
+1.33%
More